Subject: Ennov Acquires Docshifter: A Message to Our Partners

Dear Valued Partner,


We have exciting news to share that marks a significant step forward for Ennov: the acquisition of DocShifter. This strategic move is set to expand our capabilities and streamline our offerings, ensuring we continue to meet and exceed the evolving needs of the Life Sciences industry.


This acquisition reflects our commitment to growth and excellence and is pivotal in strengthening our technological foundation. The integration of DocShifter into Ennov's suite enhances our document conversion capabilities, positioning us to offer unparalleled efficiency and innovation in our services.


DocShifter and Ennov share the same mindset, the same demand for customer transparency, and the same technological vision.


We are thrilled and excited to share this news with you.

 

Ennov develops innovative, powerful and easy-to-use software for document and process management. Ennov has specialized its software to meet the specific needs of the health and life sciences sectors: Quality, Pharmacovigilance, Clinical Studies and Regulatory Affairs.

ENNOV - Olivier Pâris, 149, Avenue de France, 75013, Paris, France

You may unsubscribe or change your contact details at any time.

    This is an online snapshot of a newsletter created by the owner of Ennov EN Staff (ENNOV - Olivier Pâris, 149, Avenue de France, 75013 Paris, France) and sent via GetResponse on 2024-02-06. Report abuse